22157.jpg
Global Glycobiology Market Report 2020-2025: Focus on Drug Discovery, Disease Diagnostics, Virology, Cell Biology, & Oncology
13 janv. 2021 05h23 HE | Research and Markets
Dublin, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The "Global Glycobiology Market, By Product (Enzymes, Instruments, Reagents and Kits), By Application (Drug Discovery, Disease Diagnostics, Virology, Cell...
GO Therapeutics appo
GO Therapeutics appoints Dr. Robert J. Wills to Board of Directors
04 oct. 2017 07h30 HE | GO Therapeutics
CAMBRIDGE, Mass., Oct. 04, 2017 (GLOBE NEWSWIRE) -- GO Therapeutics, a company exploiting new advances in glycoproteomics to develop novel, multimodal first-in-class cancer therapeutics against...
Salubris Pharmaceuti
Salubris Pharmaceuticals Invests $5 Million in GO Therapeutics
25 sept. 2017 12h06 HE | GO Therapeutics
CAMBRIDGE, Mass., Sept. 25, 2017 (GLOBE NEWSWIRE) -- GO Therapeutics today announced that Salubris Pharmaceutical Limited has made a $5M investment in GO Therapeutics, a Cambridge, MA-based company...
ReportsnReports logo
Glycomics Market (Glycobiology) 2019 Worldwide Forecasts in New Research Report
04 nov. 2014 09h16 HE | ReportsnReports
DALLAS, Nov. 4, 2014 (GLOBE NEWSWIRE) -- The worldwide glycomics market (glycobiology) is expected to grow at 12.62% CAGR and reach $928.11 Million in 2019. The key drivers for this market are the...